INIO – Innio NV

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=INIO#%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

INIO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.84

Margin Of Safety %

-4

Put/Call OI Ratio

3.17

EPS Next Q Diff

0.02

EPS Last/This Y

0.22

EPS This/Next Y

0.44

Price

15.15

Target Price

31.4

Analyst Recom

1.5

Performance Q

-44.73

Upside

-88.9%

Beta

Ticker: INIO

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	INIO	16.5	5.23	0.40	35056
2026-10-15	INIO	16.5	4.86	2.54	35551
2026-10-16	INIO	16.16	4.83	0.28	35449
2026-10-19	INIO	16.02	5.90	3.10	33882
2026-10-20	INIO	16.21	5.30	0.06	36876
2026-10-21	INIO	16.85	5.19	5.68	37016
2026-10-22	INIO	15.09	5.44	0.08	37864
2026-10-23	INIO	15.2	4.55	0.24	39099
2026-10-26	INIO	16.64	4.48	0.29	39254
2026-10-27	INIO	16.97	4.40	0.27	39613
2026-10-28	INIO	18.35	4.19	0.13	40165
2026-10-29	INIO	17.5	3.80	0.38	40974
2026-10-30	INIO	16.31	3.80	0.66	41056
2026-11-02	INIO	16.41	3.66	0.09	41322
2026-11-03	INIO	18.32	3.65	0.16	41337
2026-11-04	INIO	14.73	3.60	0.36	41451
2026-11-05	INIO	13.32	3.59	0.09	41606
2026-11-06	INIO	13.75	3.32	0.05	42394
2026-11-09	INIO	14.91	3.18	0.93	42806
2026-11-10	INIO	13.78	3.14	2.53	42916
2026-11-11	INIO	15.09	3.14	3.74	43210
2026-11-12	INIO	15.2	3.17	0.06	43625
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	INIO	16.49	-	-	0.37
2026-10-15	INIO	16.49	-	-	0.37
2026-10-16	INIO	16.25	-	-	0.37
2026-10-19	INIO	16.02	-	-	0.37
2026-10-20	INIO	16.02	-	-	0.37
2026-10-21	INIO	16.23	-	-	0.37
2026-10-22	INIO	15.11	-	-	0.37
2026-10-23	INIO	15.21	-	-	0.37
2026-10-26	INIO	16.62	-	-	0.37
2026-10-27	INIO	16.97	-	-	0.37
2026-10-28	INIO	18.36	-	-	0.37
2026-10-29	INIO	17.53	-	-	0.37
2026-10-30	INIO	16.31	-	-	0.40
2026-11-02	INIO	16.42	-	-	0.40
2026-11-03	INIO	18.31	-	-	0.41
2026-11-04	INIO	14.74	-	-	0.41
2026-11-05	INIO	13.33	-	-	0.41
2026-11-06	INIO	13.76	-	-	0.41
2026-11-09	INIO	14.90	-	-	0.41
2026-11-10	INIO	13.78	-	-	0.41
2026-11-11	INIO	15.08	-	-	0.41
2026-11-12	INIO	15.15	-	-	0.41
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	INIO	-23.05	19.34	5.06
2026-10-15	INIO	-23.05	19.34	5.06
2026-10-16	INIO	-23.05	19.34	5.06
2026-10-19	INIO	-23.05	19.35	5.06
2026-10-20	INIO	-23.05	19.35	5.06
2026-10-21	INIO	-23.05	19.35	5.06
2026-10-22	INIO	-23.05	19.35	5.06
2026-10-23	INIO	-23.05	19.35	5.06
2026-10-26	INIO	-23.05	19.38	5.06
2026-10-27	INIO	-23.05	19.38	4.70
2026-10-28	INIO	-23.05	19.38	4.70
2026-10-29	INIO	-23.05	19.38	4.70
2026-10-30	INIO	-23.05	19.38	4.70
2026-11-02	INIO	-23.05	17.65	4.70
2026-11-03	INIO	-23.05	17.65	4.70
2026-11-05	INIO	-23.05	17.65	4.70
2026-11-06	INIO	-23.05	17.65	4.70
2026-11-09	INIO	-23.05	15.24	4.70
2026-11-10	INIO	-23.05	15.24	4.70
2026-11-11	INIO	-23.05	15.24	4.84
2026-11-12	INIO	-23.05	15.24	4.84
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=INIO 589 360 ]

Last Quarter Act. EPS

0.15

Avg. EPS Est. Current Quarter

0.18

Avg. EPS Est. Next Quarter

0.17

Insider Transactions

-23.05

Institutional Transactions

15.24

Beta

Average Sales Estimate Current Quarter

1219

Average Sales Estimate Next Quarter

1202

Fair Value

14.53

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

64.7

Max Drawdown 5-Year %

Target Price

31.4

P/E

119.28

Forward P/E

PEG

P/S

3.23

P/B

33.62

P/Free Cash Flow

16.11

EPS

0.13

Average EPS Est. Cur. Y

0.41

EPS Next Y. (Est.)

0.85

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

2.71

Relative Volume

0.76

Return on Equity vs Sector %

21.4

Return on Equity vs Industry %

10.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=INIO 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=INIO 589 450 ]

◆ INIO Industrials

$15.16

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

15/25

Volume

6/15

Valuation

10/20

TP/AR

4/10

Options

1/10

RSI

45.1

Range 1M

36.8%

Sup Dist

3.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

14/30

Estimates

4/20

Inst/Vol

5/15

Options

3/10

EPS Yr

EPS NY

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +6.6% upside

Quality

6/30

Valuation

5/30

Growth

9/25

Stability

2/10

LT Trend

0/5

Upside

+6.6%

Quality

MoS

-4%

INIO — P/E HistoricalSpecialty Industrial Machinery

INNIO N.V.

Sector: Industrials

Industry: Specialty Industrial Machinery

Employees: 5642

Innio N.V., through its subsidiaries, provides power generation equipment and services under the Jenbacher and Waukesha brands. It operates in two segments, Equipment and Services. The Equipment segment designs, manufactures, and sells new engines, product-related equipment, and related solutions for data center, power solutions, and compression end-markets. The Services segment provides aftermarket services through an engine's lifecycle, including service agreements, spare parts, overhauls, remanufacturing of engines and components, digital solutions, and service-related activities, as well as maintenance and replacement of parts. It also operates Myplant, an AI-enabled fleet management platform. Th company operates in Germany, rest of Europe, the United States, rest of North America, and internationally. Innio N.V. was founded in 2018 and is headquartered in Munich, Germany. Innio N.V. operates as a subsidiary of AI Alpine (Luxembourg) S.à r.l.

INIO

Latest News

—

Caricamento notizie per INIO…

stock quote shares INIO – Innio NV Stock Price stock today

news today INIO – Innio NV stock forecast ,stock prediction 2023 2024 2025

marketwatch INIO – Innio NV yahoo finance google finance

stock history INIO – Innio NV invest stock market

stock prices INIO premarket after hours

ticker INIO fair value insiders trading

EVO – Evotec SE

EVO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.02

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

-1.15

EPS This/Next Y

1.55

Price

1.68

Target Price

2.47

Analyst Recom

2.33

Performance Q

-15.31

Upside

-1,344.0%

Beta

2.02

Ticker: EVO

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	EVO	1.425	N/A	N/A	0
2026-10-15	EVO	1.415	N/A	N/A	0
2026-10-16	EVO	1.39	N/A	N/A	0
2026-10-19	EVO	1.425	N/A	N/A	0
2026-10-20	EVO	1.485	N/A	N/A	0
2026-10-21	EVO	1.55	N/A	N/A	0
2026-10-22	EVO	1.535	N/A	N/A	0
2026-10-23	EVO	1.51	N/A	N/A	0
2026-10-26	EVO	1.52	N/A	N/A	0
2026-10-27	EVO	1.565	N/A	N/A	0
2026-10-28	EVO	1.605	N/A	N/A	0
2026-10-29	EVO	1.58	N/A	N/A	0
2026-10-30	EVO	1.53	N/A	N/A	0
2026-11-02	EVO	1.52	N/A	N/A	0
2026-11-03	EVO	1.54	N/A	N/A	0
2026-11-04	EVO	1.55	N/A	N/A	0
2026-11-05	EVO	1.74	N/A	N/A	0
2026-11-06	EVO	1.695	N/A	N/A	0
2026-11-09	EVO	1.73	N/A	N/A	0
2026-11-10	EVO	1.69	N/A	N/A	0
2026-11-11	EVO	1.705	N/A	N/A	0
2026-11-12	EVO	1.67	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	EVO	1.43	-	-	-1.44
2026-10-15	EVO	1.42	-	-	-1.44
2026-10-16	EVO	1.39	-	-	-1.48
2026-10-19	EVO	1.42	-	-	-1.48
2026-10-20	EVO	1.42	-	-	-1.48
2026-10-21	EVO	1.49	-	-	-1.48
2026-10-22	EVO	1.54	-	-	-1.48
2026-10-23	EVO	1.51	-	-	-1.48
2026-10-26	EVO	1.52	-	-	-1.48
2026-10-27	EVO	1.57	-	-	-1.48
2026-10-28	EVO	1.61	-	-	-1.48
2026-10-29	EVO	1.58	-	-	-1.48
2026-10-30	EVO	1.54	-	-	-1.48
2026-11-02	EVO	1.53	-	-	-1.48
2026-11-03	EVO	1.55	-	-	-1.48
2026-11-04	EVO	1.55	-	-	-1.48
2026-11-05	EVO	1.79	-	-	-1.48
2026-11-06	EVO	1.70	-	-	-1.48
2026-11-09	EVO	1.74	-	-	-1.48
2026-11-10	EVO	1.69	-	-	-1.48
2026-11-11	EVO	1.72	-	-	-1.48
2026-11-12	EVO	1.68	-	-	-1.48
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	EVO	0.00	-0.05	0.01
2026-10-15	EVO	0.00	-0.05	0.01
2026-10-16	EVO	0.00	-0.05	0.01
2026-10-19	EVO	0.00	-3.83	0.01
2026-10-20	EVO	0.00	-3.83	0.01
2026-10-21	EVO	0.00	-3.83	0.01
2026-10-22	EVO	0.00	-3.83	0.01
2026-10-23	EVO	0.00	-3.83	0.01
2026-10-26	EVO	0.00	-3.73	0.01
2026-10-27	EVO	0.00	-3.73	0.02
2026-10-28	EVO	0.00	-3.73	0.02
2026-10-29	EVO	0.00	-3.73	0.02
2026-10-30	EVO	0.00	-3.73	0.02
2026-11-02	EVO	0.00	-3.81	0.02
2026-11-03	EVO	0.00	-3.81	0.02
2026-11-05	EVO	0.00	-3.81	0.02
2026-11-06	EVO	0.00	-3.81	0.02
2026-11-09	EVO	0.00	-3.27	0.02
2026-11-10	EVO	0.00	-3.27	0.02
2026-11-11	EVO	0.00	-3.27	0.02
2026-11-12	EVO	0.00	-3.27	0.02
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.32

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-3.27

Beta

2.02

Average Sales Estimate Current Quarter

139

Average Sales Estimate Next Quarter

215

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

93.4

Max Drawdown 5-Year %

-94.6

Target Price

2.47

P/E

Forward P/E

PEG

P/S

0.71

P/B

0.81

P/Free Cash Flow

EPS

-0.59

Average EPS Est. Cur. Y

-1.48

EPS Next Y. (Est.)

0.07

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-25.24

Relative Volume

0.44

Return on Equity vs Sector %

-54.6

Return on Equity vs Industry %

-34.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

◆ EVO Healthcare

$1.66

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

15/25

Volume

11/15

Valuation

12/20

TP/AR

2/10

Options

0/10

RSI

53.9

Range 1M

71.4%

Sup Dist

0.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

12/30

Estimates

2/20

Inst/Vol

0/15

Options

0/10

EPS Yr

-137.2%

EPS NY

70.1%

52W%

13.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +47.9% upside

Quality

2/30

Valuation

12/30

Growth

10/25

Stability

4/10

LT Trend

3/5

Upside

+47.9%

Quality

EVO — P/E HistoricalDrug Manufacturers - Specialty & Generic

Evotec SE

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 4379

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic diseases, and rare diseases. It is also developingcentral nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. In addition, it has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. Further, the company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. Evotec SE has strategic collaboration with Almirall, S.A. for the development of novel therapeutics for severe skin diseases, including a range of immune-mediated inflammatory conditions. The company collaborate with Odyssey Therapeutics, Inc. to designs and develops AI based discovery platform to discover new treatments in autoimmune and inflammatory diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

EVO

Latest News

—

Caricamento notizie per EVO…

stock quote shares EVO – Evotec SE Stock Price stock today

news today EVO – Evotec SE stock forecast ,stock prediction 2023 2024 2025

marketwatch EVO – Evotec SE yahoo finance google finance

stock history EVO – Evotec SE invest stock market

stock prices EVO premarket after hours

ticker EVO fair value insiders trading

VJET – Voxeljet AG ADR

VJET — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

16.75

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

0.54

Target Price

380

Analyst Recom

Performance Q

-81.07

Upside

-180,088.7%

Beta

-1.02

Ticker: VJET

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	VJET	0.89	N/A	N/A	0
2026-10-15	VJET	0.9704	N/A	N/A	0
2026-10-16	VJET	0.854	N/A	N/A	0
2026-10-19	VJET	0.8252	N/A	N/A	0
2026-10-20	VJET	0.7814	N/A	N/A	0
2026-10-21	VJET	0.7138	N/A	N/A	0
2026-10-22	VJET	0.6949	N/A	N/A	0
2026-10-23	VJET	0.701	N/A	N/A	0
2026-10-26	VJET	0.66	N/A	N/A	0
2026-10-27	VJET	0.6547	N/A	N/A	0
2026-10-28	VJET	0.6293	N/A	N/A	0
2026-10-29	VJET	0.6502	N/A	N/A	0
2026-10-30	VJET	0.6092	N/A	N/A	0
2026-11-02	VJET	0.5768	N/A	N/A	0
2026-11-03	VJET	0.5891	N/A	N/A	0
2026-11-04	VJET	0.5676	N/A	N/A	0
2026-11-05	VJET	0.5694	N/A	N/A	0
2026-11-06	VJET	0.5199	N/A	N/A	0
2026-11-09	VJET	0.5804	N/A	N/A	0
2026-11-10	VJET	0.5938	N/A	N/A	0
2026-11-11	VJET	0.549	N/A	N/A	0
2026-11-12	VJET	0.53	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	VJET	0.87	-	-	-
2026-10-15	VJET	0.96	-	-	-
2026-10-16	VJET	0.84	-	-	-
2026-10-19	VJET	0.83	-	-	-
2026-10-20	VJET	0.83	-	-	-
2026-10-21	VJET	0.78	-	-	-
2026-10-22	VJET	0.69	-	-	-
2026-10-23	VJET	0.70	-	-	-
2026-10-26	VJET	0.64	-	-	-
2026-10-27	VJET	0.64	-	-	-
2026-10-28	VJET	0.62	-	-	-
2026-10-29	VJET	0.65	-	-	-
2026-10-30	VJET	0.61	-	-	-
2026-11-02	VJET	0.56	-	-	-
2026-11-03	VJET	0.55	-	-	-
2026-11-04	VJET	0.56	-	-	-
2026-11-05	VJET	0.57	-	-	-
2026-11-06	VJET	0.53	-	-	-
2026-11-09	VJET	0.58	-	-	-
2026-11-10	VJET	0.58	-	-	-
2026-11-11	VJET	0.55	-	-	-
2026-11-12	VJET	0.54	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	VJET	0.00	0	0.96
2026-10-15	VJET	0.00	0	0.96
2026-10-16	VJET	0.00	0	3.54
2026-10-19	VJET	0.00	0	3.54
2026-10-20	VJET	0.00	0	3.54
2026-10-21	VJET	0.00	0	3.54
2026-10-22	VJET	0.00	0	3.54
2026-10-23	VJET	0.00	0	3.54
2026-10-26	VJET	0.00	0	3.54
2026-10-27	VJET	0.00	0	50.89
2026-10-28	VJET	0.00	0	50.89
2026-10-29	VJET	0.00	0	50.89
2026-10-30	VJET	0.00	0	50.89
2026-11-02	VJET	0.00	0	50.89
2026-11-03	VJET	0.00	0	50.89
2026-11-05	VJET	0.00	0	50.89
2026-11-06	VJET	0.00	0	50.89
2026-11-09	VJET	0.00	4.96	50.89
2026-11-10	VJET	0.00	4.96	50.89
2026-11-11	VJET	0.00	4.96	16.75
2026-11-12	VJET	0.00	4.96	16.75
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

4.96

Beta

-1.02

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

100

Max Drawdown 5-Year %

-100

Target Price

380

P/E

Forward P/E

PEG

P/S

0.58

P/B

0.01

P/Free Cash Flow

EPS

-73.38

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-711.49

Relative Volume

0.11

Return on Equity vs Sector %

-84.4

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ VJET Industrials

$0.53

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

13/25

Volume

11/15

Valuation

12/20

TP/AR

2/10

Options

0/10

RSI

29.4

Range 1M

7.9%

Sup Dist

1.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

11/30

Estimates

1/20

Inst/Vol

4/15

Options

0/10

EPS Yr

EPS NY

52W%

0.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +71598.1% upside

Quality

3/30

Valuation

16/30

Growth

5/25

Stability

4/10

LT Trend

1/5

Upside

+71598.1%

Quality

VJET — P/E HistoricalComputer Hardware

Flyte Aviation, Inc.

Sector: Industrials

Industry: Airports & Air Services

Employees: 17

Flyte Aviation, Inc. provides on-demand private aviation charter services. The company operates two service lines, Hops and Luxe, for private air travel. Through Hops, the company offers short-haul private charter services using company-managed aircraft on regional routes across the New York Metro Area, Long Island, New England, and the Eastern seaboard. The company also enables customers to bid on available empty-leg flights in real time through Hops. Through Luxe, the company offers a brokerage service that matches passengers seeking larger or longer-range aircraft with vetted third-party aircraft operators and crews for on-demand charters and bespoke travel coordination. The company also operates a direct-to-consumer mobile application and website that handles flight booking, scheduling, pricing, payment, and dispatch. It serves private aviation travelers across the Northeast, Southeast, and select other regional markets in the United States. It also manufactures health care equipment. Flyte Aviation, Inc. was formerly known as Catheter Precision, Inc. and changed its name to Flyte Aviation, Inc. in October 2026. Flyte Aviation, Inc. was founded in 2002 and is based in Fort Mill, South Carolina.

VJET

Latest News

—

Caricamento notizie per VJET…

stock quote shares VJET – Voxeljet AG ADR Stock Price stock today

news today VJET – Voxeljet AG ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch VJET – Voxeljet AG ADR yahoo finance google finance

stock history VJET – Voxeljet AG ADR invest stock market

stock prices VJET premarket after hours

ticker VJET fair value insiders trading

IMTX – Immatics N.V

IMTX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.87

Margin Of Safety %

Put/Call OI Ratio

2.1

EPS Next Q Diff

0.1

EPS Last/This Y

-0.25

EPS This/Next Y

0.03

Price

6.5

Target Price

16.62

Analyst Recom

Performance Q

-30.93

Upside

-492.8%

Beta

1.36

Ticker: IMTX

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	IMTX	7.01	0.14	0.07	1722
2026-10-15	IMTX	7.14	0.14	0.07	1722
2026-10-16	IMTX	6.71	0.14	100.00	1736
2026-10-19	IMTX	7.06	0.55	0.00	332
2026-10-20	IMTX	7.51	0.55	0.00	332
2026-10-21	IMTX	7.69	0.54	0.00	337
2026-10-22	IMTX	7.54	0.54	0.00	337
2026-10-23	IMTX	7.32	0.45	0.00	379
2026-10-26	IMTX	7.16	0.45	0.00	379
2026-10-27	IMTX	7.26	0.40	0.00	410
2026-10-28	IMTX	7.34	0.40	0.00	412
2026-10-29	IMTX	7.32	0.18	0.00	773
2026-10-30	IMTX	7.2	0.18	5.00	775
2026-11-02	IMTX	7.04	0.52	0.00	935
2026-11-03	IMTX	7.07	0.58	0.00	865
2026-11-04	IMTX	6.9	0.58	0.00	865
2026-11-05	IMTX	6.17	0.83	45.64	699
2026-11-06	IMTX	6.36	0.83	45.73	699
2026-11-09	IMTX	6.42	0.83	45.73	699
2026-11-10	IMTX	6.42	0.83	45.73	699
2026-11-11	IMTX	6.7	2.10	0.00	1211
2026-11-12	IMTX	6.5	2.10	8.00	1210
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	IMTX	7.02	-3.2	-	-2.07
2026-10-15	IMTX	7.14	-3.2	-	-2.07
2026-10-16	IMTX	6.71	-2.7	-	-2.06
2026-10-19	IMTX	7.06	-2.7	-	-2.06
2026-10-20	IMTX	7.06	-2.7	-	-2.06
2026-10-21	IMTX	7.50	-2.7	-	-2.06
2026-10-22	IMTX	7.53	-2.7	-	-2.06
2026-10-23	IMTX	7.31	-2.7	-	-2.06
2026-10-26	IMTX	7.15	-2.7	-	-2.06
2026-10-27	IMTX	7.26	-2.7	-	-2.06
2026-10-28	IMTX	7.34	-2.7	-	-2.06
2026-10-29	IMTX	7.32	-2.7	-	-2.06
2026-10-30	IMTX	7.19	-2.2	-	-2.05
2026-11-02	IMTX	7.04	-2.2	-	-2.05
2026-11-03	IMTX	7.08	-2.2	-	-2.05
2026-11-04	IMTX	6.89	-2.2	-	-2.05
2026-11-05	IMTX	6.16	-2.2	-	-2.05
2026-11-06	IMTX	6.35	-1.7	-	-2.04
2026-11-09	IMTX	6.43	-1.7	-	-2.04
2026-11-10	IMTX	6.43	-1.7	-	-2.04
2026-11-11	IMTX	6.70	-1.7	-	-2.04
2026-11-12	IMTX	6.50	-1.7	-	-2.04
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	IMTX	4.10	-4.75	2.89
2026-10-15	IMTX	4.10	-4.75	2.89
2026-10-16	IMTX	4.10	-4.75	2.89
2026-10-19	IMTX	4.10	-4.43	2.89
2026-10-20	IMTX	4.10	-4.43	2.89
2026-10-21	IMTX	4.10	-4.43	2.89
2026-10-22	IMTX	4.10	-4.43	2.89
2026-10-23	IMTX	4.10	-4.43	2.89
2026-10-26	IMTX	4.10	-4.33	2.89
2026-10-27	IMTX	4.10	-4.33	2.93
2026-10-28	IMTX	4.10	-4.33	2.93
2026-10-29	IMTX	4.10	-4.33	2.93
2026-10-30	IMTX	4.10	-4.33	2.93
2026-11-02	IMTX	4.10	-4.34	2.93
2026-11-03	IMTX	4.10	-4.34	2.93
2026-11-05	IMTX	4.10	-4.34	2.93
2026-11-06	IMTX	4.10	-4.34	2.93
2026-11-09	IMTX	4.10	-4.43	2.93
2026-11-10	IMTX	4.10	-4.43	2.93
2026-11-11	IMTX	4.10	-4.43	2.87
2026-11-12	IMTX	4.10	-4.43	2.87
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.58

Avg. EPS Est. Current Quarter

-0.5

Avg. EPS Est. Next Quarter

-0.48

Insider Transactions

4.1

Institutional Transactions

-4.43

Beta

1.36

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

53.6

Max Drawdown 5-Year %

-74.1

Target Price

16.62

P/E

Forward P/E

PEG

P/S

19.32

P/B

1.99

P/Free Cash Flow

EPS

-1.97

Average EPS Est. Cur. Y

-2.04

EPS Next Y. (Est.)

-2

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-533.26

Relative Volume

0.86

Return on Equity vs Sector %

-78.6

Return on Equity vs Industry %

-59.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

◆ IMTX Healthcare

$6.52

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

10/20

Pullback

23/25

Volume

7/15

Valuation

12/20

TP/AR

2/10

Options

2/10

RSI

37.9

Range 1M

17.2%

Sup Dist

1.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

10/25

Growth

7/30

Estimates

0/20

Inst/Vol

0/15

Options

3/10

EPS Yr

-18.1%

EPS NY

-1.1%

52W%

5.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +154.9% upside

Quality

2/30

Valuation

15/30

Growth

2/25

Stability

7/10

LT Trend

1/5

Upside

+154.9%

Quality

IMTX — P/E HistoricalBiotechnology

Immatics N.V.

Sector: Healthcare

Industry: Biotechnology

Employees: 589

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes Anzu-cel (IMA203), a one-time infusion PRAME cell therapy, which is in Phase 2 trial; IMA203CD8, a cell therapy product that is in Phase 1 clinical trial; IMA204 that targets tumor stroma, which is in Phase 1 clinical trial; and Anzu-cel in combination with Moderna's PRAME cell therapy enhancer (mRNA-4203), which is in Phase 1 clinical trial. The company also develops TCR Bispecifics products, including IMA401 and IMA402, which is in Phase 1a clinical trial. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.

IMTX

Latest News

—

Caricamento notizie per IMTX…

stock quote shares IMTX – Immatics N.V Stock Price stock today

news today IMTX – Immatics N.V stock forecast ,stock prediction 2023 2024 2025

marketwatch IMTX – Immatics N.V yahoo finance google finance

stock history IMTX – Immatics N.V invest stock market

stock prices IMTX premarket after hours

ticker IMTX fair value insiders trading

FMS – Fresenius Medical Care AG ADR

FMS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.58

Margin Of Safety %

Put/Call OI Ratio

2.38

EPS Next Q Diff

EPS Last/This Y

0.62

EPS This/Next Y

-0.1

Price

21.59

Target Price

19.98

Analyst Recom

4.25

Performance Q

-9.17

Upside

4.8%

Beta

0.74

Ticker: FMS

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	FMS	21.55	0.98	0.07	3157
2026-10-15	FMS	22.12	0.98	0.00	3160
2026-10-16	FMS	22.17	0.97	999.99	3161
2026-10-19	FMS	21.94	0.97	999.99	3161
2026-10-20	FMS	21.41	0.71	999.99	2009
2026-10-21	FMS	21.56	0.85	103.93	2176
2026-10-22	FMS	22.23	1.76	75.00	3285
2026-10-23	FMS	22.67	1.88	0.00	3437
2026-10-26	FMS	22.75	1.88	0.00	3437
2026-10-27	FMS	22.5	1.35	5.56	3899
2026-10-28	FMS	22.62	1.35	5.56	3899
2026-10-29	FMS	23.11	1.42	0.00	3994
2026-10-30	FMS	22.47	1.42	999.99	3994
2026-11-02	FMS	22.6	1.48	0.80	4094
2026-11-03	FMS	21.73	1.48	1.44	4094
2026-11-04	FMS	23.18	1.39	0.81	4041
2026-11-05	FMS	23.67	1.30	77.59	4375
2026-11-06	FMS	23.4	2.09	0.33	5895
2026-11-09	FMS	22.95	2.09	6.00	5895
2026-11-10	FMS	22.74	2.09	2.73	5894
2026-11-11	FMS	22.2	2.38	1.10	6579
2026-11-12	FMS	21.59	2.38	1.10	6579
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	FMS	21.55	-8.0	124.6	2.08
2026-10-15	FMS	22.11	-8.0	144.4	2.08
2026-10-16	FMS	22.16	-7.7	91.8	2.09
2026-10-19	FMS	21.93	-7.7	75.1	2.09
2026-10-20	FMS	21.93	-7.7	75.1	2.09
2026-10-21	FMS	21.41	-7.7	59.8	2.09
2026-10-22	FMS	22.23	-3.8	112.3	2.08
2026-10-23	FMS	22.68	-3.8	101.3	2.08
2026-10-26	FMS	22.75	-3.8	85.8	2.07
2026-10-27	FMS	22.50	-3.8	76.6	2.07
2026-10-28	FMS	22.62	-3.8	99.3	2.07
2026-10-29	FMS	23.11	-3.8	112.9	2.07
2026-10-30	FMS	22.47	-3.8	47.4	2.07
2026-11-02	FMS	22.61	-3.8	87.1	2.07
2026-11-03	FMS	21.72	-3.8	32.1	2.07
2026-11-04	FMS	23.18	-26.7	239.6	2.05
2026-11-05	FMS	23.66	-26.7	193.3	2.05
2026-11-06	FMS	23.41	-48.9	168.9	2.00
2026-11-09	FMS	22.95	-48.9	37.2	2.00
2026-11-10	FMS	22.75	-29.3	29.9	2.07
2026-11-11	FMS	22.21	-29.3	30.3	2.48
2026-11-12	FMS	21.59	-29.3	38.1	2.48
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	FMS	0	0.26	0.53
2026-10-15	FMS	0	0.26	0.53
2026-10-16	FMS	0	0.26	0.53
2026-10-19	FMS	0	0.29	0.53
2026-10-20	FMS	0	0.29	0.53
2026-10-21	FMS	0	0.29	0.53
2026-10-22	FMS	0	0.29	0.53
2026-10-23	FMS	0	0.29	0.53
2026-10-26	FMS	0	0.27	0.53
2026-10-27	FMS	0	0.27	0.74
2026-10-28	FMS	0	0.27	0.74
2026-10-29	FMS	0	0.27	0.74
2026-10-30	FMS	0	0.27	0.74
2026-11-02	FMS	0	0.14	0.74
2026-11-03	FMS	0	0.14	0.74
2026-11-05	FMS	0	0.14	0.74
2026-11-06	FMS	0	0.14	0.74
2026-11-09	FMS	0	0.53	0.76
2026-11-10	FMS	0	0.53	0.76
2026-11-11	FMS	0	0.53	0.58
2026-11-12	FMS	0	0.53	0.58
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.51

Avg. EPS Est. Next Quarter

0.49

Insider Transactions

Institutional Transactions

0.53

Beta

0.74

Average Sales Estimate Current Quarter

5012

Average Sales Estimate Next Quarter

4746

Fair Value

23.75

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

38.4

Max Drawdown 5-Year %

-62.3

Target Price

19.98

P/E

12.42

Forward P/E

9.93

PEG

21.14

P/S

0.5

P/B

0.77

P/Free Cash Flow

5.39

EPS

1.74

Average EPS Est. Cur. Y

2.48

EPS Next Y. (Est.)

2.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.22

Relative Volume

2.73

Return on Equity vs Sector %

-20

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

0.4

EPS 1 30Days Diff

0.41

EBIT Estimation

38.1

◆ FMS Healthcare

$21.59

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

12/20

Pullback

11/25

Volume

0/15

Valuation

14/20

TP/AR

0/10

Options

3/10

RSI

42.5

Range 1M

24.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

1/30

Estimates

3/20

Inst/Vol

6/15

Options

1/10

EPS Yr

-9.6%

EPS NY

-4.6%

52W%

25.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +23.2% upside

Quality

6/30

Valuation

11/30

Growth

1/25

Stability

4/10

LT Trend

5/5

Upside

+23.2%

Quality

MoS

10%

FMS — P/E HistoricalMedical Care Facilities

Fresenius Medical Care AG

Sector: Healthcare

Industry: Medical Care Facilities

Employees: 106291

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

FMS

Latest News

—

Caricamento notizie per FMS…

stock quote shares FMS – Fresenius Medical Care AG ADR Stock Price stock today

news today FMS – Fresenius Medical Care AG ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch FMS – Fresenius Medical Care AG ADR yahoo finance google finance

stock history FMS – Fresenius Medical Care AG ADR invest stock market

stock prices FMS premarket after hours

ticker FMS fair value insiders trading

FMS – Fresenius Medical Care AG & Co. KGaA

FMS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.58

Margin Of Safety %

Put/Call OI Ratio

2.38

EPS Next Q Diff

EPS Last/This Y

0.62

EPS This/Next Y

-0.1

Price

21.59

Target Price

19.98

Analyst Recom

4.25

Performance Q

-9.17

Upside

4.8%

Beta

0.74

Ticker: FMS

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	FMS	21.55	0.98	0.07	3157
2026-10-15	FMS	22.12	0.98	0.00	3160
2026-10-16	FMS	22.17	0.97	999.99	3161
2026-10-19	FMS	21.94	0.97	999.99	3161
2026-10-20	FMS	21.41	0.71	999.99	2009
2026-10-21	FMS	21.56	0.85	103.93	2176
2026-10-22	FMS	22.23	1.76	75.00	3285
2026-10-23	FMS	22.67	1.88	0.00	3437
2026-10-26	FMS	22.75	1.88	0.00	3437
2026-10-27	FMS	22.5	1.35	5.56	3899
2026-10-28	FMS	22.62	1.35	5.56	3899
2026-10-29	FMS	23.11	1.42	0.00	3994
2026-10-30	FMS	22.47	1.42	999.99	3994
2026-11-02	FMS	22.6	1.48	0.80	4094
2026-11-03	FMS	21.73	1.48	1.44	4094
2026-11-04	FMS	23.18	1.39	0.81	4041
2026-11-05	FMS	23.67	1.30	77.59	4375
2026-11-06	FMS	23.4	2.09	0.33	5895
2026-11-09	FMS	22.95	2.09	6.00	5895
2026-11-10	FMS	22.74	2.09	2.73	5894
2026-11-11	FMS	22.2	2.38	1.10	6579
2026-11-12	FMS	21.59	2.38	1.10	6579
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	FMS	21.55	-8.0	124.6	2.08
2026-10-15	FMS	22.11	-8.0	144.4	2.08
2026-10-16	FMS	22.16	-7.7	91.8	2.09
2026-10-19	FMS	21.93	-7.7	75.1	2.09
2026-10-20	FMS	21.93	-7.7	75.1	2.09
2026-10-21	FMS	21.41	-7.7	59.8	2.09
2026-10-22	FMS	22.23	-3.8	112.3	2.08
2026-10-23	FMS	22.68	-3.8	101.3	2.08
2026-10-26	FMS	22.75	-3.8	85.8	2.07
2026-10-27	FMS	22.50	-3.8	76.6	2.07
2026-10-28	FMS	22.62	-3.8	99.3	2.07
2026-10-29	FMS	23.11	-3.8	112.9	2.07
2026-10-30	FMS	22.47	-3.8	47.4	2.07
2026-11-02	FMS	22.61	-3.8	87.1	2.07
2026-11-03	FMS	21.72	-3.8	32.1	2.07
2026-11-04	FMS	23.18	-26.7	239.6	2.05
2026-11-05	FMS	23.66	-26.7	193.3	2.05
2026-11-06	FMS	23.41	-48.9	168.9	2.00
2026-11-09	FMS	22.95	-48.9	37.2	2.00
2026-11-10	FMS	22.75	-29.3	29.9	2.07
2026-11-11	FMS	22.21	-29.3	30.3	2.48
2026-11-12	FMS	21.59	-29.3	38.1	2.48
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	FMS	0	0.26	0.53
2026-10-15	FMS	0	0.26	0.53
2026-10-16	FMS	0	0.26	0.53
2026-10-19	FMS	0	0.29	0.53
2026-10-20	FMS	0	0.29	0.53
2026-10-21	FMS	0	0.29	0.53
2026-10-22	FMS	0	0.29	0.53
2026-10-23	FMS	0	0.29	0.53
2026-10-26	FMS	0	0.27	0.53
2026-10-27	FMS	0	0.27	0.74
2026-10-28	FMS	0	0.27	0.74
2026-10-29	FMS	0	0.27	0.74
2026-10-30	FMS	0	0.27	0.74
2026-11-02	FMS	0	0.14	0.74
2026-11-03	FMS	0	0.14	0.74
2026-11-05	FMS	0	0.14	0.74
2026-11-06	FMS	0	0.14	0.74
2026-11-09	FMS	0	0.53	0.76
2026-11-10	FMS	0	0.53	0.76
2026-11-11	FMS	0	0.53	0.58
2026-11-12	FMS	0	0.53	0.58
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.51

Avg. EPS Est. Next Quarter

0.49

Insider Transactions

Institutional Transactions

0.53

Beta

0.74

Average Sales Estimate Current Quarter

5012

Average Sales Estimate Next Quarter

4746

Fair Value

23.75

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

38.4

Max Drawdown 5-Year %

-62.3

Target Price

19.98

P/E

12.42

Forward P/E

9.93

PEG

21.14

P/S

0.5

P/B

0.77

P/Free Cash Flow

5.39

EPS

1.74

Average EPS Est. Cur. Y

2.48

EPS Next Y. (Est.)

2.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.22

Relative Volume

2.73

Return on Equity vs Sector %

-20

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

0.4

EPS 1 30Days Diff

0.41

EBIT Estimation

38.1

◆ FMS Healthcare

$21.59

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

12/20

Pullback

11/25

Volume

0/15

Valuation

14/20

TP/AR

0/10

Options

3/10

RSI

42.5

Range 1M

24.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

1/30

Estimates

3/20

Inst/Vol

6/15

Options

1/10

EPS Yr

-9.6%

EPS NY

-4.6%

52W%

25.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +23.2% upside

Quality

6/30

Valuation

11/30

Growth

1/25

Stability

4/10

LT Trend

5/5

Upside

+23.2%

Quality

MoS

10%

FMS — P/E HistoricalMedical Care Facilities

Fresenius Medical Care AG

Sector: Healthcare

Industry: Medical Care Facilities

Employees: 106291

FMS

Latest News

—

Caricamento notizie per FMS…

stock quote shares FMS – Fresenius Medical Care AG & Co. KGaA Stock Price stock today

news today FMS – Fresenius Medical Care AG & Co. KGaA stock forecast ,stock prediction 2023 2024 2025

marketwatch FMS – Fresenius Medical Care AG & Co. KGaA yahoo finance google finance

stock history FMS – Fresenius Medical Care AG & Co. KGaA invest stock market

stock prices FMS premarket after hours

ticker FMS fair value insiders trading

No more stocks to show

INIO – Innio NV

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: INIO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

EVO – Evotec SE

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: EVO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y